coriolis campus

Coriolis Pharma to build new campus in Martinsried-Munich

Coriolis Pharma, a globally operating contract research and development organization (CRDO) and one of the world leaders in formulation research and development of (bio)pharmaceutical drugs, ATMP´s and vaccines, is expanding its current headquarters to form a new campus as the next step in its growth strategy.

lifespin

Lifespin to collaborate wth Biobank Graz to expand database of metabolic profiles for novel oncology diagnostics platform

Regensburg, Germany-based Lifespin, has entered a collaborative agreement with Biobank Graz and the Clinical Division of Oncology of the Medical University of Graz to expand its database of metabolic human health profiles in the field of oncology. Under the agreement, Lifespin will be able to analyze and capture the metabolic profiles from more than 25,000 […]

Medix Biochemica

Medix Biochemica acquires Bioresource Technology

Medix Biochemica has acquired 100 percent of the shares of Bioresource Technology (BRT) to broaden its base matrix capabilities and further strengthen its local presence in the US market. As a result of this partnership, Medix Biochemica will provide its customers with a comprehensive offering of raw materials for their IVD quality control products. The […]

Minaris

Ixaka and Minaris Regenerative Medicine sign tech transfer, manufacturing agreement for cell therapy candidate REX-001

Ixaka, an integrated cell and gene therapy company, and Minaris Regenerative Medicine, a leading contract development and manufacturing service provider for the cell and gene therapy industry, have signed an agreement to enable technology transfer as well as clinical and commercial manufacture of REX-001, Ixaka’s lead autologous multi-cell therapy (MCT) being developed for the treatment […]

heart 1481125922

CardiNor inks US distribution agreement with IBL-America for the CardiNor Secretoneurin ELISA test

Cardiovascular DX company CardiNor AS has signed an exclusive agreement with IBL-America for sales of the CardiNor Secretoneurin ELISA test in the US. By initially targeting research institutes, clinical research organisations and pharmaceutical companies, CardiNor aims to spread awareness of this important new frontline biomarker and pave the way for future commercialisation upon US regulatory […]

fujifilm Digital pathology

Fujifilm commits to digital pathology

Fujifilm is at the forefront of the digital histopathology revolution, centred around the Dynamyx software by Inspirata, and supported by partnerships that drive improvements in patient care.

Olympus Provi CM20 1

Olympus Provi CM20 wins highest honour in Red Dot Design Award

The Olympus Provi CM20 incubation monitoring system has won the prestigious “Best of the Best” award in the Product Design category of the 2022 Red Dot Design Award. This Award is bestowed on a product that the Red Dot Jury deems as groundbreaking and is the highest honour given in this world-renowned design competition.

ProteoNic

ProteoNic licenses 2G UNic technology platform for production of biologics to FyoniBio

ProteoNic, a leading provider of premium vector technology and services for production of biologics, and FyoniBio, a contract development organization for biopharmaceuticals, have entered into a technology licensing agreement. Under the agreement, FyoniBio gains worldwide, non-exclusive commercial rights for application of ProteoNic techno-logy in its proprietary CHOnamite platform. As a result, FyoniBio’s clients will profit […]

MIC

Microchip Imaging Cytometry set to make quantitative lab testing more economical, easy-to-use, and accessible

Scientific and technical advances in the field of Microchip Imaging Cytometry (MIC) are set to advance quantitative diagnostic testing that may deliver more economical, easy-to-use, and accessible healthcare to the public, according to a new article published in Opto-Electronic Advances [1].

cannabis

Existing drug tests can detect delta-8-THC – the latest cannabis craze

As the cannabis derivative delta-8-THC grows in popularity, it’s important for drug tests to be able to detect and differentiate it from delta-9-THC – the primary psychoactive ingredient in cannabis. Breaking research showcased at the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo demonstrates that common drug testing methods can do just that.